Zai Lab Ltd. Files 8-K Report
Ticker: ZLAB · Form: 8-K · Filed: Nov 15, 2024 · CIK: 1704292
| Field | Detail |
|---|---|
| Company | Zai Lab Ltd (ZLAB) |
| Form Type | 8-K |
| Filed Date | Nov 15, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.000006, $25.50, $189 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Zai Lab filed an 8-K on Nov 14, 2024, reporting a material definitive agreement.
AI Summary
On November 14, 2024, Zai Lab Ltd. entered into a material definitive agreement. The company, incorporated in the Cayman Islands with principal executive offices in Shanghai, China, filed this 8-K report with the SEC.
Why It Matters
This filing indicates a significant event for Zai Lab Ltd., potentially involving new agreements or material changes that could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, requiring further analysis to understand their full impact.
Key Numbers
- 001-38205 — SEC File Number (Identifies Zai Lab Ltd.'s filing with the SEC.)
Key Players & Entities
- Zai Lab Ltd (company) — Registrant
- November 14, 2024 (date) — Earliest event reported
- Cayman Islands (jurisdiction) — State of incorporation
- Shanghai, China (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Zai Lab Ltd. on November 14, 2024?
The filing does not specify the details of the material definitive agreement, only that one was entered into on November 14, 2024.
What is Zai Lab Ltd.'s primary business?
Zai Lab Ltd. is in the Pharmaceutical Preparations industry, with SIC code 2834.
Where are Zai Lab Ltd.'s principal executive offices located?
Zai Lab Ltd.'s principal executive offices are located at 4560 Jinke Road, Bldg. 1, Fourth Floor, Pudong, Shanghai, China, 201210.
When is Zai Lab Ltd.'s fiscal year end?
Zai Lab Ltd.'s fiscal year ends on December 31.
What is the SEC file number for Zai Lab Ltd.?
Zai Lab Ltd.'s SEC file number is 001-38205.
Filing Stats: 1,025 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2024-11-15 17:23:33
Key Financial Figures
- $0.000006 — resenting 10 Ordinary Shares, par value $0.000006 per share ZLAB The Nasdaq Global Ma
- $25.50 — share, at a public offering price of US$25.50 per ADS (the "Offering"). All of the AD
- $189 m — eeds from the Offering of approximately $189 million, excluding proceeds from any exer
Filing Documents
- d781798d8k.htm (8-K) — 33KB
- d781798dex11.htm (EX-1.1) — 239KB
- d781798dex51.htm (EX-5.1) — 17KB
- d781798dex991.htm (EX-99.1) — 10KB
- g781798g1115094608438.jpg (GRAPHIC) — 5KB
- g781798g1115094608627.jpg (GRAPHIC) — 5KB
- g781798g1115095227018.jpg (GRAPHIC) — 3KB
- 0001193125-24-259957.txt ( ) — 548KB
- zlab-20241114.xsd (EX-101.SCH) — 3KB
- zlab-20241114_def.xml (EX-101.DEF) — 14KB
- zlab-20241114_lab.xml (EX-101.LAB) — 23KB
- zlab-20241114_pre.xml (EX-101.PRE) — 15KB
- d781798d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated November 14, 2024, by and among the Company and the Underwriters 5.1 Opinion of Travers Thorp Alberga 23.1 Consent of Travers Thorp Alberga (included in Exhibit 5.1 above) 99.1 Pricing Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZAI LAB LIMITED Dated: November 15, 2024 By: /s/ Joshua Smiley Joshua Smiley President and Chief Operating Officer